Thanh T. Hoang, PhD
- Cancer and Blood Disorders
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Departments:
Office location:
1102 Bates Avenue
Houston, TX 77030
Get to know Thanh T. Hoang, PhD
Education
| School | Education | Degree | Year |
|---|---|---|---|
| National Institute of Environmental Health Sciences - NIEHS | Post-doctoral Fellowship | Genetics, Environment & Respiratory Disease Group, Epidemiology Branch | 2021 |
| The University of Texas Health Science Center at Houston, School of Public Health | PhD | Doctor of Philosophy, Epidemiology | 2018 |
| University of Rochester | Bachelors | Bachelor of Science, Epidemiology | 2013 |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
How Texas Children’s Cancer and Hematology Center Works...
Research Area:
Epidemiology (Cancer and Hematology)
Thanh Hoang is a member of the Epidemiology and Population Sciences Program at Texas Children's Cancer and Hematology Center. Her research sits at the intersection between environmental health and molecular biology – with a direct application to pediatric populations.
Early in her career, she analyzed genetic and non-genetic factors to improve our understanding of the etiology and survival outcomes of infants with birth defects – conditions that are strongly associated with pediatric cancer. During her postdoctoral fellowship, she gained expertise in examining how environmental toxicants impacts epigenetics throughout the life course, which may inform the development of methylation risk score biomarkers that could be applied to studies of pediatric cancer.
Her long-term research goal is to utilize novel exposure methods to develop a comprehensive approach to evaluate the interplay between environmental exposures and genetic susceptibility on the risk of developing and treating pediatric cancer.